Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms
Rodrigues, Felipe F., Morais, Marcela I., Melo, Ivo S. F., Augusto, Paulo S. A., Dutra, Marcela M. G. B., Costa, Sarah O. A. M., Costa, Fábio C., Goulart, Franciele A., Braga, Alysson V., Coelho, MárcJournal:
Inflammopharmacology
DOI:
10.1007/s10787-019-00670-w
Date:
November, 2019
File:
PDF, 1.27 MB
2019
File converter
More search results
More benefits 
